Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GDC-8264 for the Prevention of Acute Kidney Injury in Cardiac Surgery
NCT06602453Phase 2Terminated
- Sponsor
- Genentech
- Start
- Jan 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of GDC-8264 in acute kidney injury (AKI), sponsored by Genentech. Started Jan 2025; status: terminated.
02
Drugs
GDC-8264
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT06602453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06602453.